Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to
Condition: Prevention of Swine InfluenzaIntervention: Biological: Swine InfluenzaSponsor: Novartis VaccinesCompleted - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Influenza | Influenza Vaccine | Research | Swine Flu | Swine Flu (H1N1) Vaccine | Vaccines